Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
スポンサーリンク
概要
- 論文の詳細を見る
Recent international summits of the International Federation of Societies of Toxicologic Pathologists (IFSTP) have debated the desirability and potential means by which the proficiency of an individual toxicologic pathologist might be recognized and communicated throughout the world. The present document describes the advantages and disadvantages of implementing such a global recognition system by any means, and provides a proposal whereby recognition might be accorded via rigorous credential review of a practitioner's education and experience.
- 日本毒性病理学会の論文
著者
-
Konishi Yoichi
Yamamoto Green Village
-
Black Hugh
Hugh E. Black & Associates Inc.
-
Ettlin Robert
Ettlin Consulting Ag
-
BOLON Brad
GEMpath Inc.
-
PYRAH Ian
Amgen Inc.
関連論文
- Global Recognition of Qualified Toxicologic Pathologists : Where We Are Now and Where We Need to Go
- Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples
- Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings
- International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies
- Successful Drug Development Despite Adverse Preclinical Findings : Part 2 : Examples
- Successful Drug Development Despite Adverse Preclinical Findings : Part 1 : Processes to Address Issues and Most Important Findings
- Global Recognition of Qualified Toxicologic Pathologists : Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
- The World Weighs in on Optimal Practices for Training Toxicologic Pathologists : Consensus has been Reached
- Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies